US2017095360A1PendingUtilityA1
Methods of fabricating stents with enhanced fracture toughness
Assignee: ABBOTT CARDIOVASCULAR SYSTEMS INCPriority: Jun 15, 2006Filed: Dec 15, 2016Published: Apr 6, 2017
Est. expiryJun 15, 2026(expired)· nominal 20-yr term from priority
B29C 49/4823A61L 31/148B29C 2793/0009B29K 2067/046B29C 69/001A61F 2002/91533B29C 55/22A61F 2/91Y10T156/1026A61F 2210/0004A61L 31/06A61F 2002/91583A61F 2/90B29K 2105/258B29C 35/045B29K 2995/006A61F 2002/91566B29C 49/4273A61L 31/14B29C 55/24A61F 2002/91558B29C 49/14A61F 2/9522B29L 2031/7534A61F 2/915B29K 2067/00A61F 2220/0016B29C 49/0005B29C 2949/08B29C 2049/7831
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Stents and methods of manufacturing a stents with enhanced fracture toughness are disclosed.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method of treating a blood vessel with a biodegradable stent comprising
deploying a biodegradable stent in a blood vessel from a crimped diameter to an intended deployment diameter, the biodegradable stent including a cylindrically-shaped scaffold extending longitudinally from a proximal end to a distal end, the scaffold comprising a poly(L-lactide)-based biodegradable polymer, wherein the scaffold includes a pattern comprising a first cylindrical ring of struts adjacent to a second cylindrical ring of struts, wherein the first cylindrical ring of struts includes first bending elements with curved portions having apices and the second cylindrical ring of struts includes second bending elements with curved portions having apices, wherein apices pointing to a proximal end of the scaffold of the first bending elements are longitudinally aligned with the apices pointing to the distal end of the scaffold of the second bending elements, wherein longitudinal linking struts connect the first cylindrical ring with the second cylindrical ring, the scaffold formed by cutting the pattern in a tube, wherein the curved portions bend outward when the scaffold is deployed to allow for radial expansion of the scaffold, wherein no cracks form in the curved portions of the first and second bending elements when the stent is deployed to the intended deployment diameter.
3 . The method of claim 2 , wherein the tube has been processed to increase crystallinity prior to cutting, the biodegradable polymer after the processing has a crystallinity of less than 50%.
4 . The method of claim 3 , wherein the biodegradable polymer after the processing has a crystallinity less than 40%.
5 . The method of claim 2 , wherein curved portions of the bending elements have no cracks at the crimped diameter,
6 . The method of claim 2 , wherein the bending elements have an angle greater than 90° at a diameter the pattern is cut, and wherein the scaffold has adequate radial strength to hold open the blood vessel.
7 . The method of claim 3 , wherein the processing comprises radially expanding the tube to an expanded diameter prior to forming the pattern in the tube at the expanded diameter, the radial expansion providing induced molecular orientation in the circumferential direction in the scaffold.
8 . The method of claim 2 , wherein the scaffold has induced molecular orientation in the circumferential direction.
9 . The method of claim 3 , wherein the processing comprises heating the tube to a temperature above a glass transition temperature (Tg) of the biodegradable polymer.
10 . The method of claim 2 , wherein the bending elements have an angle greater than 110° at the diameter the pattern is cut.Join the waitlist — get patent alerts
Track US2017095360A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.